Updates are available Correction dated 2019-03-27
Click to view Correction: https://doi.org/10.1038/s41591-019-0433-3
Updates are available Correction dated 2025-04-25
Click to view Correction: https://doi.org/10.1038/s41591-025-03713-8
-
Authors
Kinsey, Conan G.
Camolotto, Soledad A.
Boespflug, Amelie M.
Guillen, Katrin P.
Foth, Mona https://orcid.org/0000-0001-6507-8114
Truong, Amanda
Schuman, Sophia S.
Shea, Jill E.
Seipp, Michael T.
Yap, Jeffrey T.
Burrell, Lance D.
Lum, David H.
Whisenant, Jonathan R.
Gilcrease, G. Weldon III
Cavalieri, Courtney C.
Rehbein, Kaitrin M.
Cutler, Stephanie L.
Affolter, Kajsa E.
Welm, Alana L.
Welm, Bryan E.
Scaife, Courtney L.
Snyder, Eric L.
McMahon, Martin https://orcid.org/0000-0003-2812-1042
- License Information
-
More Information
Article History
Received: 18 June 2018
Accepted: 17 January 2019
First Online: 4 March 2019
Change Date: 27 March 2019
Change Type: Correction
Change Details: In the version of this article initially published, the label over the bottom schematic in Fig. 1a was “pH > 5.0”; it should have been “pH < 5.0”. Further, the original article misspelt the surname of Katrin P. Guillen as “Gullien”. These errors have been corrected in the print, PDF and HTML versions of the article.
Change Date: 25 April 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-025-03713-8
Competing interests
: M.M. served on external advisory boards for Novartis (June 2017), Genentech (December 2017) and Merck (June 2018). M.M. is the recipient of research funding from Pfizer, through a grant peer-reviewed, co-funded and awarded by the Melanoma Research Alliance.
